← Back to Search

Behavioural Intervention

CYT - Prehab Yoga Intervention + ERAS for Ovarian Cancer

N/A
Waitlist Available
Led By Lois Ramondetta, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment.
2. Able to read, write, and speak English.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year
Awards & highlights

Summary

To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.

Who is the study for?
This trial is for women with ovarian, fallopian tube, or primary peritoneal cancer who are about to start chemotherapy and have surgery planned. Details on specific inclusion and exclusion criteria are not provided.
What is being tested?
The study tests a Comprehensive Yoga Therapy (CYT) program designed as prehabilitation for nutritional, physical, and psychosocial support before patients undergo chemotherapy and surgery.
What are the potential side effects?
Yoga therapy is generally low-risk but may include muscle soreness or strain. The impact on individuals will vary based on their health condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
1. safety and adverse events (AEs). Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Trial Design

2Treatment groups
Experimental Treatment
Group I: WLC - Wait List Control + ERASExperimental Treatment1 Intervention
Group II: CYT - Prehab Yoga Intervention + ERASExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,030 Previous Clinical Trials
1,797,203 Total Patients Enrolled
47 Trials studying Ovarian Cancer
16,745 Patients Enrolled for Ovarian Cancer
Lois Ramondetta, MDPrincipal InvestigatorM.D. Anderson Cancer Center
~29 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top